2023 The Final Countdown, page-481

That’s all good…..but I’m thinking he felt it was a ‘done deal’ last time as well. As we weren’t privy to back room conversations last time but given the obvious disappointment displayed by Si & Dr Rose after the CRL…..those discussions at numerous meetings must have been very upbeat & positive before the CRL dumped them & investors right on their heads. Here’s hoping the anticipation & elation is not misplaced this time around by one & all….eg aduhem approval comes to mind as a recent example of how the FDA can surprise the market in the other direction. Their hand picked ODAC voted unanimously 10-0 NOT to approve it…..yet it was approved. Add to the fact that 2 AD patients died shortly thereafter from known side effects….one can only wonder ….nervously….what makes them tick.